Increased sodium -lithium countertransport activity (SLC) associates with hypertension and is highly heritable, yet the underlying genes remain unknown. SLC, measured on 1113 and remeasured 2-3 years later on 675 adult members of 48 Utah pedigrees, was tested for candidate gene association, major locus inheritance, and linkage to genome scan markers using a bivariate model with genotype-specific effects of age, body mass index (BMI), and triglycerides level (TG). No effect of the a-adducin Gly460Trp polymorphism on SLC was found. In contrast, SLC increased with age in carriers of apolipoproteinE e2 (85 individuals; 8.7% of the sample) and decreased in noncarriers. Model-fitting analyses inferred two additional loci with genotype-specific responses to BMI and TG. Using the inferred model, lod scores 42 were obtained for D3S3038, D11S4464, and D10S677 for the BMI-responsive locus, and for D8S1048 for the TG-responsive locus.
Introduction
Increased sodium -lithium countertransport activity (SLC) in hypertensive patients was first reported over 20 years ago. 1 Many studies since support the hypertension association; in addition, hyperlipidemia and possibly diabetic nephropathy associate with increased SLC. 2 SLC is highly heritable with heritability X65% estimated in Utah pedigrees. 3, 4 Nevertheless, no studied polymorphism affects SLC more than modestly (b 3 -adrenergic receptor Trp64Arg, 5 a-adducin (ADD1) Gly460Trp 6,7 ), while others are non-significant (Na-H antiporter, 8, 9 angiotensin-converting enzyme insertion/deletion, 10,11 G-protein b 3 -subunit C825T 12 ) or inconsistent (blood group MNS, 10, 13 haptoglobin, 10,13 apolipoproteinE (apoE) 14, 15 ).
Genome scans have implicated various genomic locations. Variance components linkage analysis applied to nuclear family data produced lod ¼ 2.83 on chromosome 15q at marker D15S642 16 and applied to baboon pedigrees produced lod ¼ 9.3 on chromosome 5, in the region homologous to human chromosome 4q near marker D4S1645. 17 Genome-wide association analysis of SLC in immortalized lymphoblasts identified multiple associations, many with markers near genes involved in glutathione metabolism. 18 Herein, we analyzed SLC measured twice at a 2 -3 years interval on members of 48 pedigrees. We tested for association with ADD1 and apoE polymorphisms, fit genetic models, and tested for linkage to genome-wide markers.
Subjects and methods
A total of 98 Utah pedigrees were ascertained through 2 -3 siblings with stroke death before age 74, hypertensive and normotensive subjects from the Salt Lake Center of the Hypertension Detection and Followup Program, and men with coronary disease onset before age 55. Approximately 2500 members of the extended pedigrees were examined in 1980. Over 90% were re-examined in 1983. The study, described extensively elsewhere, 19 We used measured genotype analysis to test whether ADD1 or apoE affected SLC by fixing each individual's genotype to his/her observed genotype in a one-locus version of the model described above. In each case, the sample was restricted to genotyped individuals.
The model-fitting analyses assumed the model described above with three unlinked loci, two alleles at each locus, and additivity across the loci. 28 One locus represented apoE by fixing each individual's genotype to his/her observed apoE genotype; apoE allele frequencies were fixed at estimates obtained from the sample assuming HardyWeinberg equilibrium and all familial relationships. The global maximum likelihood of the model was obtained through repeated searches of the likelihood surface starting from different sets of parameter values. Linkage analysis of each marker to each of the two unidentified loci assumed the inferred three-locus model using PAP. 26 To speed computation, pedigree-specific lods included only informative marker alleles (producing a twoallele lod exceeding 70.1 for recombination ¼ 0.05 for the designated allele versus all others) and multiallelic lods were computed only for promising markers (sum 40 of the two-allele lods across alleles and pedigrees) and for unpromising markers (sum oÀ1.5). ApoE was genotyped on 981 sample members. The frequencies of alleles e2, e3, and e4 (0.056, 0.772, and 0.172, respectively) resemble estimates from comparable populations. 31 Because of small numbers, genotypes e2/e2
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(N ¼ 2) and e2/e4 (N ¼ 16) were combined with e2/e3 (N ¼ 67) and e4/e4 (N ¼ 21) was combined with e3/e4 (N ¼ 282). The effects of e3 and e4 did not differ (w 2 (4) ¼ 1.41, P ¼ 0.84), so further comparisons were limited to e2 carriers (N ¼ 85) and noncarriers. Genotype-specific effects on SLC were not significant for BMI (w In addition to apoE, two unidentified loci affected SLC. Genotype-specific slopes differed significantly only for age for apoE, only for BMI at a second locus, and only for TG at a third locus (Table 2) . None remained significant in univariate analysis after excluding repeat measurements ( Table 2 ). The parsimonious model (all nonsignificant effects made genotype-constant) did not differ from the full model (w 2 (10) ¼ 10.39, P ¼ 0.41). Allele frequencies were estimated as 0.165 and 0.218 for the BMI-and TGresponsive loci, respectively. We partitioned the withingenotype variance as 50.4% to polygenes, 15.4% to measurement date, and the remaining 34.2% to random environmental effects. The within-genotype environmental correlation between exams was estimated as 15.9%. Figure 1 shows individual Exam 1 to Exam 2 changes with age in SLC by e2 carrier status. Annual rates of change, computed as Exams 1 and 2 transformed adjusted SLC difference divided by elapsed time, differed significantly between e2 carriers and noncarriers (t ¼ 2.24, P ¼ 0.026). Figure 1 also shows the inferred slopes with age in e2 carriers and noncarriers. SLC was measured on our sample 20 þ years ago. Since then, kinetic studies have shown that variation in activity reflects independent variation in V max and k m . 37 The hypertension association has been attributed to lower k m, 38 whereas the hyperlipidemia association has been attributed to higher V max . 37 Possibly, the BMI-and TGresponsive loci affect k m and V max , respectively. The genotype-specific responsiveness of SLC to BMI or TG implies that weight loss or lipid reduction decreases SLC. In agreement, lipid reduction decreased SLC, 39 -41 through decreased V max with unchanged k m . 41 However, SLC remained unchanged following weight loss accompanied by decreased TG, but the sample included only eight women. 42 Our model predicts a substantial response only in the subset of individuals with the responsive genotype. The three major loci accounted for roughly 26% (apoE: 1%; BMI-responsive: 20%; TG-responsive: 5%) of the total or 40 -45% of the genetic variance of SLC. Computational constraints prohibited attempting inference of a fourth locus. Possibly 10 þ additional loci underlie the remaining 55 -60% of the genetic variance, assuming each contributes less than the TG-responsive locus. The numerous marker associations 18 reported also support the presence of many genes. ADD1 may be one of the additional genes, although, if so, we lacked sufficient power for confirmation. Other studies report that ADD1 affects SLC, but differ as to whether 460Trp decreases 7 or increases 6 SLC. Neither finding necessarily contradicts ours, since our model, although nonsignificant, estimates a steeper decrease with age and a steeper increase with BMI in 460Trp homozygotes compared to 460Gly homozygotes. Consequently, the ordering of the means across genotypes depends, as does the power, on the age and BMI profile of the sample. Another possibility, that ADD1 is the inferred BMIresponsive locus, is unlikely given the lack of evidence of linkage to markers on chromosome 4p16.3 near ADD1. In contrast to ADD1, apoE attained significance; SLC increased with age in e2 carriers and decreased in noncarriers. The small estimated difference in the slopes made significance surprising, but demonstrated the power inherent in measured, compared to unmeasured, genotypes. We estimated that e2 carriers have lower SLC before and higher SLC after age 45 At the TG-responsive locus, the rare homozygotes had the lowest SLC at low TG but the highest SLC at high TG, possibly because the linearity assumption is invalid. The TG-responsive locus produced only one suggestive linkage, to D8S1048, 4.6 cM on the LDB2000 map from the b 3 -adrenergic receptor, for which SLC associates with Trp64Arg. 5 Although failing the suggestive linkage threshold, D10S1221 (lod ¼ 1.75) and D8S2324 (lod ¼ 1.55) fall on the Marshfield map o1 and 1.1 cM, respectively, from markers D10S122 and D8S1475 found to associate with SLC. 18 Standard segregation analysis of SLC on this sample inferred major locus inheritance in only the pedigrees ascertained through coronary heart disease, but not stroke or hypertension, 4 motivating the inclusion herein of multiple loci to model genetic heterogeneity. In a previous attempt to dissect the heterogeneity, segregation analysis of principal component (PC) scores supported major locus inheritance of three scores to which SLC contributed substantially. 43 For PC1, homozygotes for a common allele showed higher SLC, BMI, and TG. For PC9, heterozygotes for a rare allele had higher SLC, but lower BMI. For PC11, homozygotes for a rare allele had higher SLC, but lower TG. Two-point model-based linkage analysis produced lod ¼ 2.05 for PC1 with D3S3038 (Table 3) , lod ¼ 1.58 for SLC and lod ¼ 1.54 for PC9 each with D1S160 (Table 4) , and lod ¼ 1.36 for PC9 with D1S1612 (Table 4) . No other Table 3 or 4 markers produced lod41 and no other lod42 was obtained from two-point linkage analysis using the previously inferred models for SLC or the three scores. Significant linkage evidence occasionally, but rarely, results when using models inferred from segregation analysis. 44, 45 At fault may be the simplicity of standard segregation analysis models. In contrast, herein, we allowed for locus heterogeneity and genotype-specific covariate effects, and obtained higher lods than were obtained with the simpler model discussed above, and also higher lods than using variance components linkage analysis, which produced no lod42 for either Exam 1 or Exam 2 SLC (results not shown). In summary, we conclude that at least three genes affect SLC. For apoE, SLC increased significantly with age in e2 carriers and decreased in noncarriers. In addition to apoE, we inferred that two unidentified loci, one showing a genotype-specific response to changes in BMI and the other showing a genotype-specific response to changes in TG. Lod scores 42 were obtained for markers D3S3038, D11S4464, and D10S677 for the BMI-responsive locus, and for D8S1048 for the TG-responsive locus. Model-fitting and linkage analysis of SLC SJ Hasstedt et al
